Naturally occurring and synthetic inhibitors of NF-κB functions

Anti-Cancer Drug Design

Volumn 15, Issue 4, 2000, Pages 239-244

  Umezawa, K ^a   Ariga, A ^a   Matsumoto, N ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 DEHYDROXYMETHYLEPOXYQUINOMICIN C DERIVATIVE; CELL ADHESION MOLECULE; CYCLOEPOXYDON; EPOXYQUINOMICIN C; GAMMA INTERFERON; GLIOTOXIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN KAPPA CHAIN; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; PANEPOXYDONE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CIRCULAR DICHROISM; CYTOKINE RELEASE; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; PRIORITY JOURNAL; PROTEIN INDUCTION; RACEMIC MIXTURE; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; STEREOCHEMISTRY; X RAY CRYSTALLOGRAPHY;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; DRUG DESIGN; HUMANS; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 0034489187     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Manumycin A: Synthesis of the (+)-enantiomer and revision of stereochemical assignment
2. Suppression of TNF-α-induced apoptosis by NF-κB
3. IκB-NF-κB structures: At the interface of inflammation control
4. NF-κB: Ten years after
5. Function and activation of NF-kappa B in the immune system
6. The NF-κB and IκB proteins: New discoveries and insights
7. An essential role for NF-κB in preventing TNF-α-induced cell death
8. New stereoselective route to the epoxyquinol core of manumycin-type natural products synthesis of enantiopure (+)-bromoxone, (-)-LL-C10037a, and (+)-KT 8110
9. An endotoxin-induced serum factor that causes necrosis of tumors
10. Contenders in FasL/TNF death signaling
11. Inhibition of NF-κB activation by panepoxydone
12. Downstream AKTion blocks apoptosis
13. Cycloepoxydon, 1-hydroxy-2-hydroxymethyl-3-pent- 1-enylbenzene and 1-hydroxy-2-hydroxymethyl-3-pent-1,3-dienylbenzene, new inhibitors of eukaryotic signal transduction
14. The TNF-receptor 1-associated protein TRADD signals cell death and NF-κB activation
15. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways
16. 7N core of the manumycin family: Preparation of (+)-MT 35214 and a formal total synthesis of (-)-alisamycin
17. Epoxyquinomicins A, B, C and D, new antibiotics from Amycolatopsis. I. Taxonomy, fermentation, isolation and antimicrobial activities
18. Epoxyquinomicins A, B, C and D, new antibiotics from Amycolatopsis. II. Effect on type II collagen-induced arthritis in mice
19. Synthesis of NF-κB activation inhibitors derived from epoxyquinomicin C
20. Tumor necrosis factor (TNF)
21. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase
22. The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-κB
23. Herbimycin A accelerates the induction of apoptosis following etoposide treatment or gamma-irradiation of bcr/abl-positive leukaemia cells
24. NF-κB is a target of Akt in antiapoptotic PDGF signalling
25. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis
26. Multiple nuclear factors interact with the immunoglobulin enhancer sequences
27. Polyoxypeptins A and B produced by Streptomyces: Apoptosis-inducing cyclic depsipeptides containing the novel amino acid (2S, 3R)-3-hydroxy-3-methylproline
28. Chloptosin, an apoptosis-inducing dimeric cyclohexapeptide produced by Streptomyces
29. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB
30. Synthesis of the antitumor antibiotic LL-C10037a
31. Synthesis of optically active 2,3-epoxycyclohexanone and the determination of its absolute configuration